Shares of Prime Medicine (NASDAQ: PRME) are surging on Thursday. The gene-editing company's stock gained 10.5% as of 2 p.m.

Mind Medicine (NASDAQ: MNMD) stock is seeing impressive gains Friday. The company's share price was up 16.9% as of 3:15 p.m. ET and had been up as much as 20.7% on the day earlier in the session.

Prime Medicine, Inc. (PRME) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Mind Medicine (NASDAQ: MNMD) stock is posting big gains in Tuesday's trading. The biotech company's share price was up 8.7% as of 2 p.m. ET despite a 0.8% pullback for the S&P 500 index and a 1.5% ...

Shares of Prime Medicine, Inc. (NASDAQ:PRME) fell 19.2% following the company’s announcement of a strategic restructuring focused on large genetic liver diseases and cystic fibrosis, alongside ...

That doesn't mean that MindMed stock isn't worth owning, but investors will definitely need to be patient with this name. 10 stocks we like better than Mind Medicine (MindMed) Inc.

Shares of Prime Medicine (NASDAQ: PRME) are surging on Thursday. The gene-editing company's stock gained 10.5% as of 2 p.m. ET and was up as much as 17% earlier in the day. The move up comes as ...